耦联因子-6与高血压及其并发症的研究进展
出处
《疑难病杂志》
CAS
2007年第11期692-694,共3页
Chinese Journal of Difficult and Complicated Cases
基金
国家重点基础研究发展计划(国家973计划)资助项目(No.2005CB523300)
参考文献14
-
1Osanai T, Kamada T, Fujiwara N, et al. A novel inhibitory, effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneously hypertensive rats [J].J Biol Chem, 1998, 27 , 273 ( 48 ) : 31 778- 31 783.
-
2任永生,李菊香,唐朝枢.新发现的内源性缩血管多肽—偶联因子6[J].高血压杂志,2003,11(1):10-13. 被引量:3
-
3Osanai T,Tanaka M, Kamada T, et al. Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor[J] .J Clin Invest,2001,108(7):1 023- 1 030.
-
4Osanai T, Okada S, Sirato K, et al. Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress[J]. Circulation,2001,104:3 132-3 136.
-
5Osanai T, Magota K, Tanaka M, et al. lntracellular signaling for vasocon- strictor coupling factor 6 : novel function of β-subunit of ATP synthase as receptor[ J ]. Hypertension, 2005,46 : 1 140-1 146.
-
6Harwalkar S, Chang CH, Dulin NO, et al. Role of phospholipase A2 isozymes in agonist-mediated signaling in proximal tubular pithelium[ J]. H wpertension 1998,31 : 809-814.
-
7Tomita H, Osanai T, Toki T, et al. Troglitazone and 15 deoxy delta prostaglandin inhibit shear-induced coupling factor 6 release in endothelial cells[J]. Cardiovasc Res. 2005,67: 34-141.
-
8任永生,蒋宏峰,蒋维,庞永正,孙宁玲,高连如,丁文杰,唐朝枢,蔡大勇.高血压病人血浆线粒体偶联因子6的变化[J].高血压杂志,2003,11(1):19-21. 被引量:6
-
9Osanai T, Sasaki S, Kamada T, et al. Circulating coupling factor 6 in human hypertension: role of reactive oxygen species[ J]. Hyphertens, 2003,21 (12) :2 323-2 328.
-
10Stephanie W, Watts. Vasoconstriction caused by the ATP synthase subunit-coupling factor 6:a new function for a hisorical enzyme[J]. Hypertension,2005,46:1 100-1 102.
二级参考文献19
-
1金咸.花生四烯酸与低氧性肺动脉高压[J].基础医学与临床,1996,16(1):26-30. 被引量:9
-
2[1]Higuti T, Tsurumic C, Kanamura Y, et al. Molecular cloning of cDNA for the import precursor of human coupling factor 6 of H+-ATP synthase in mitochondria[J].Biochem Biophys Res Commun,1991,178(2),793-799.
-
3[2]Osanai T, Kamada T, Fujiwara N, et al. A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneously hypertensive[J].J Biol Chem, 1998,27;273(48):31778-31783.
-
4[3]Osanai T, Tanaka M, Kamada T, et al. Molecular coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress[J].Circulation,2001,104:3132-3136.
-
5[4]Osanai T, Tanaka M, Kamada T, et al. Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor[J].J Clin Invest,2001,108(7):1023-1030.
-
6[5]Chinenov Y,Coombs C, Martin ME, et al. Isolation of a bi-directional promoter directing expression of the mouse GABPalpha and ATP synthase coupling factor 6 genes[J].Gene,2000 ,261(2):311-320.
-
7[6]Himeda T, Morokami K, Arakaki N, et al. Synchronized transcriptional gene expression of H+-ATP synthase subunits in different tissues of Fischer 344 rats of different ages[J].European Journal of Biochemistry,2000,267(23):6938-6942.
-
8[7]Sharifi AM, Schiffrin EL. Apoptosis in vasculature of spontaneously hypertensive rats: effect of anangiotensin converting enzyme inhibitor and a calcium channel antagonist[J].Am J Hypertens,1998, 11:1108-1116.
-
9[8]Fortuno MA, Ravassa S, Etayo JC, et al. Overexpression of Bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats: effects of AT1 blockade with losartan[J].Hypertension,1998,32:580-586.
-
10[9]Sangawa H, Himeda T, Shibata H, et al. Gene expression of subunit c (P1), subunit c(P2), and oligomycin sensitivity-conferring protein may play a key role in biogenesis of H+ -ATP synthase in various rat tissues[J].J Biol Chem,1997,272:6034-6037.
共引文献15
-
1潘小华,王智勇.吸烟与冠心病发生发展关系的研究进展[J].中西医结合心脑血管病杂志,2007,5(1):53-54. 被引量:3
-
2张春莲,赵亚娟,吕跃峰,梁江红,陈双郧.妊娠期高血压疾病患者血浆线粒体偶联因子6的变化[J].郧阳医学院学报,2008,27(3):218-220.
-
3朱海燕,赖爱鸾,张李松.激素替代治疗联合降压药物对围绝经期原发性高血压妇女血压及内皮功能的影响[J].中国全科医学,2008,11(16):1448-1450. 被引量:12
-
4贾永平,孙晋亮,吕吉元,范春雨,高宇平.介入治疗对冠心病患者血浆偶联因子6的影响及其机制分析[J].中国心血管病研究,2008,6(8):564-566. 被引量:1
-
5池瑞芳,贾永平,吕吉元,范春雨,高宇平,王睿,贾永平,吕吉元,范春雨,高宇平,王睿.急性心肌梗死合并阻塞性呼吸睡眠暂停综合征患者偶联因子6水平的变化[J].中西医结合心脑血管病杂志,2009,7(3):367-368. 被引量:4
-
6许飞,陈道桢,杨敏,王俊峰,潘栋辉.子痫前期患者血浆CF6、6-Keto-PG_(F1α)和RLX测定的意义[J].放射免疫学杂志,2010,23(5):483-486. 被引量:3
-
7马健,徐岩.代谢综合征患者血浆线粒体偶联因子-6含量变化[J].心血管康复医学杂志,2011,20(4):319-321.
-
8陈峰,庞继恩,孙强,盛斌,姜靖,刘志涛,孙晓峰,崔静.急性心肌梗死患者血清高敏肌钙蛋白T及线粒体偶联因子-6含量的变化[J].中国循证心血管医学杂志,2012,4(5):431-433. 被引量:3
-
9章海燕,龙明智,吴智文.偶联因子6水平在慢性心力衰竭中的变化及与预后的关系[J].医学临床研究,2013,30(2):234-236. 被引量:2
-
10刘涌,陈峰,庞继恩,刘志涛,甄玉改,崔静.慢性心力衰竭患者血清线粒体偶联因子-6含量变化及意义[J].西南军医,2013,15(4):366-368. 被引量:1
-
1马健,李明春.老年高血压患者左室肥厚与血浆线粒体耦联因子-6的关系[J].中国老年学杂志,2014,34(8):2235-2236. 被引量:1
-
2王艳,李伶.耦联因子6对糖尿病血管病变的研究进展[J].国际检验医学杂志,2010,31(6):591-592. 被引量:1
-
3孙辉,高彦辉.白细胞介素-10与心血管疾病[J].国外医学(免疫学分册),2003,26(3):137-141. 被引量:2
-
4马健,庞继恩.血浆线粒体耦联因子-6在冠心病患者冠脉循环中的变化及与病变程度的相关性[J].中国老年学杂志,2011,31(20):3881-3882.
-
5姚民秀,李颖,李盈,李兵晖,赵桂欣.2型糖尿病病人血清铁蛋白的变化及意义[J].青岛大学医学院学报,2000,36(2):123-124. 被引量:6
-
6任永生,李菊香,唐朝枢.新发现的内源性缩血管多肽—偶联因子6[J].高血压杂志,2003,11(1):10-13. 被引量:3
-
7马健,孙贤春.急性心肌梗死冠脉循环血浆线粒体偶联因子-6水平变化[J].实用医药杂志,2009,26(9):22-23. 被引量:1
-
8高艳芳,唐敏,王丽君.白介素-10与心血管疾病[J].医学信息(西安上半月),2006,19(1):180-181.
-
9刘明阳,张振晓,赫建帅,辛丽丽,牟迪.血清IL-10及IL-18与糖尿病性视网膜病变的相关性[J].青岛大学医学院学报,2013,49(6):524-525.
-
10谭建聪,刘光耀,刘晓莉,徐有奇.高血压病患者红细胞Ca^2+内流的变化及与血压关系的初步探讨[J].山西医药杂志,1994,23(4):225-226. 被引量:2